SALT LAKE CITY, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, was informed on Friday, November 1, 2024, of an updated ...

Vatnsdal covers the Healthcare sector, focusing on stocks such as Myriad Genetics, Thermo Fisher, and Envista Holdings. Currently, the analyst consensus on Waters is a Hold with an average price ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Bristol-Myers Squibb (BMY – Research Report) and Envista ...

The Agricultural Research and Technology Center (ARTC) will include customized laboratories, greenhouses and capacity for ...